Penumbra, Inc. (PEN)

NYSE Health Care Health Care Equipment S&P MidCap 400

$319.21

-1.90 (-0.59%)

Close of Nov 06, 2026 · end-of-day data

Source: Penumbra, Inc.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$263.32M	$333.76M	$444.94M	$547.40M	$560.41M	$747.59M	$847.13M	$1.06B	$1.19B	$1.40B
Cost of revenue	$92.49M	$116.62M	$152.41M	$175.44M	$222.24M	$272.21M	$311.93M	$375.88M	$439.62M	$461.23M
Gross profit	$170.83M	$217.14M	$292.53M	$371.96M	$338.18M	$475.38M	$535.21M	$682.64M	$755.00M	$942.44M
Research & development	$23.88M	$31.66M	$36.16M	$51.72M	$90.05M	$104.55M	$79.41M	$84.42M	$94.78M	$89.77M
Selling, general & admin	$148.30M	$184.32M	$226.38M	$272.73M	$287.07M	$378.33M	$449.72M	$506.45M	$573.99M	$663.42M
Operating income	-$1.35M	$1.17M	-$852.00K	$47.51M	-$38.94M	-$7.50M	$6.08M	$73.55M	$9.28M	$189.25M
Interest expense	—	—	—	—	—	$1.93M	$1.75M	$1.74M	$1.42M	$1.31M
Pre-tax income	-$869.00K	$2.48M	$1.61M	$50.13M	-$38.02M	-$10.50M	$3.89M	$79.65M	$20.87M	$205.12M
Income tax	-$15.68M	-$3.61M	-$4.40M	$3.13M	-$18.76M	-$13.12M	$5.89M	-$11.30M	$6.86M	$27.44M
Net income	$14.81M	$4.66M	$6.60M	$48.46M	-$15.70M	$5.28M	-$2.00M	$90.95M	$14.01M	$177.69M
EBITDA	$947.00K	$4.95M	$5.32M	$55.61M	-$26.05M	$8.91M	$30.40M	$100.81M	$32.98M	$206.72M
EPS (basic)	$0.49	$0.14	$0.19	$1.39	$-0.44	$0.14	$-0.05	$2.37	$0.36	$4.57
EPS (diluted)	$0.44	$0.13	$0.18	$1.34	$-0.44	$0.14	$-0.05	$2.32	$0.36	$4.52
Diluted shares	33.48M	35.32M	36.09M	36.27M	35.77M	37.88M	37.84M	39.22M	39.27M	39.29M
Gross margin	64.9%	65.1%	65.7%	68.0%	60.3%	63.6%	63.2%	64.5%	63.2%	67.1%
Operating margin	-0.5%	0.3%	-0.2%	8.7%	-6.9%	-1.0%	0.7%	6.9%	0.8%	13.5%
Net margin	5.6%	1.4%	1.5%	8.9%	-2.8%	0.7%	-0.2%	8.6%	1.2%	12.7%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$13.24M	$50.64M	$67.85M	$72.78M	$69.67M	$59.38M	$69.86M	$167.49M	$324.40M	$186.90M
Short-term investments	—	—	—	—	$195.16M	$195.50M	$118.17M	$121.70M	$15.73M	$357.92M
Receivables	$43.34M	$58.01M	$81.90M	$105.90M	$114.61M	$133.94M	$203.38M	$201.77M	$167.67M	$190.02M
Inventory	$73.01M	$94.90M	$115.74M	$152.99M	$219.53M	$263.50M	$334.01M	$388.02M	$406.74M	$431.55M
Total current assets	$263.83M	$382.23M	$410.73M	$463.13M	$617.70M	$681.47M	$755.70M	$915.40M	$951.12M	$1.22B
Goodwill	$0	$8.18M	$7.81M	$7.66M	$8.37M	$166.39M	$166.05M	$166.27M	$165.83M	$166.75M
Total assets	$308.25M	$476.67M	$515.01M	$665.90M	$822.98M	$1.24B	$1.37B	$1.56B	$1.53B	$1.83B
Total current liabilities	$35.80M	$51.58M	$66.06M	$91.05M	$105.93M	$123.20M	$144.93M	$151.14M	$158.34M	$183.13M
Total liabilities	$41.71M	$76.26M	$92.59M	$180.29M	$185.19M	$290.32M	$372.03M	$377.36M	$382.25M	$398.92M
Shareholders' equity	$266.55M	$400.41M	$422.24M	$485.89M	$641.50M	$953.93M	$998.86M	$1.18B	$1.15B	$1.43B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$12.81M	$12.69M	$28.81M	$26.65M	-$33.24M	$9.50M	-$55.66M	$97.33M	$168.48M	$238.66M
Capital expenditures	$13.63M	$12.53M	$9.60M	$22.11M	$24.76M	$21.18M	$19.30M	$15.21M	$21.18M	$63.73M
Free cash flow	-$26.44M	$159.00K	$19.20M	$4.54M	-$58.00M	-$11.68M	-$74.96M	$82.12M	$147.30M	$174.93M
Investing cash flow	$687.00K	-$77.65M	-$385.00K	-$12.71M	-$104.15M	-$21.73M	$54.79M	-$16.08M	$77.62M	-$404.59M
Financing cash flow	$7.13M	$104.36M	-$9.81M	-$8.96M	$134.92M	$836.00K	$11.62M	$16.20M	-$87.01M	$26.53M
Share buybacks	—	—	—	—	—	—	$0	$0	$100.39M	$0
Stock-based compensation	$14.64M	$17.81M	$18.42M	$21.48M	$25.54M	$65.76M	$37.38M	$50.52M	$46.16M	$59.21M
Depreciation & amortization	$2.30M	$3.78M	$6.17M	$8.10M	$12.89M	$16.41M	$24.32M	$27.26M	$23.70M	$17.47M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$284.68M	$278.65M	$299.40M	$301.04M	$315.52M	$324.14M	$339.45M	$354.69M	$385.38M	$374.76M	$390.05M	$410.14M
Cost of revenue	$97.69M	$97.52M	$136.57M	$100.73M	$104.80M	$108.26M	$115.44M	$114.27M	$123.26M	$121.35M	$125.10M	$129.84M
Gross profit	$186.99M	$181.14M	$162.83M	$200.31M	$210.72M	$215.88M	$224.01M	$240.42M	$262.13M	$253.41M	$264.94M	$280.30M
Research & development	$21.94M	$24.63M	$24.94M	$25.20M	$20.01M	$22.08M	$23.22M	$22.68M	$21.79M	$22.38M	$25.40M	$25.36M
Selling, general & admin	$130.02M	$144.41M	$141.90M	$139.74M	$147.94M	$153.46M	$159.96M	$168.90M	$181.10M	$192.79M	$198.51M	$204.20M
Operating income	$35.03M	$12.10M	-$80.96M	$35.36M	$42.77M	$40.35M	$40.83M	$48.84M	$59.23M	$38.23M	$41.04M	$50.74M
Interest expense	$436.00K	$402.00K	$344.00K	$336.00K	$337.00K	$322.00K	$319.00K	$338.00K	$333.00K	$317.00K	$311.00K	$305.00K
Pre-tax income	$38.16M	$14.63M	-$77.87M	$39.78M	$44.34M	$43.86M	$45.31M	$52.33M	$63.63M	$41.69M	$46.19M	$56.32M
Income tax	-$16.06M	$3.62M	-$17.67M	$10.25M	$10.66M	$4.63M	$40.00K	$6.47M	$16.29M	$9.10M	$11.38M	$14.04M
Net income	$54.22M	$11.00M	-$60.20M	$29.53M	$33.68M	$39.22M	$45.27M	$45.85M	$47.34M	$32.58M	$34.81M	$42.28M
EBITDA	$42.07M	$19.62M	-$73.31M	$39.51M	$47.16M	$45.37M	$46.34M	$51.33M	$63.69M	$42.81M	$46.65M	$56.20M
EPS (basic)	$1.40	$0.28	$-1.55	$0.76	$0.87	$1.02	$1.17	$1.17	$1.21	$0.83	$0.88	$1.07
EPS (diluted)	$1.38	$0.28	$-1.55	$0.75	$0.87	$1.00	$1.15	$1.17	$1.20	$0.82	$0.88	$1.07
Diluted shares	39.29M	39.39M	38.79M	39.18M	561.23K	39.16M	39.25M	39.30M	41.15K	39.54M	39.57M	39.62M
Gross margin	65.7%	65.0%	54.4%	66.5%	66.8%	66.6%	66.0%	67.8%	68.0%	67.6%	67.9%	68.3%
Operating margin	12.3%	4.3%	-27.0%	11.7%	13.6%	12.4%	12.0%	13.8%	15.4%	10.2%	10.5%	12.4%
Net margin	19.0%	3.9%	-20.1%	9.8%	10.7%	12.1%	13.3%	12.9%	12.3%	8.7%	8.9%	10.3%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$167.49M	$223.11M	$288.33M	$280.48M	$324.40M	$376.05M	$421.77M	$321.03M	$186.90M	$241.29M	$205.27M	$254.28M
Short-term investments	$121.70M	$90.36M	$51.36M	$10.55M	$15.73M	$2.79M	$2.79M	$149.27M	$357.92M	$374.37M	$453.52M	$419.33M
Receivables	$201.77M	$191.99M	$200.83M	$176.05M	$167.67M	$167.98M	$175.54M	$183.43M	$190.02M	$183.29M	$190.41M	$195.22M
Inventory	$388.02M	$398.37M	$373.80M	$393.41M	$406.74M	$415.86M	$427.63M	$432.37M	$431.55M	$438.54M	$442.65M	$459.13M
Total current assets	$915.40M	$935.02M	$943.79M	$891.75M	$951.12M	$999.71M	$1.07B	$1.14B	$1.22B	$1.28B	$1.34B	$1.38B
Goodwill	$166.27M	$166.10M	$166.05M	$166.35M	$165.83M	$166.12M	$166.75M	$166.75M	$166.75M	$166.59M	$166.52M	$166.48M
Total assets	$1.56B	$1.58B	$1.53B	$1.48B	$1.53B	$1.59B	$1.67B	$1.74B	$1.83B	$1.90B	$1.97B	$2.03B
Total current liabilities	$151.14M	$152.80M	$150.99M	$153.19M	$158.34M	$158.63M	$157.76M	$169.60M	$183.13M	$211.73M	$233.78M	$233.81M
Total liabilities	$377.36M	$376.31M	$373.33M	$374.84M	$382.25M	$380.43M	$380.86M	$385.67M	$398.92M	$424.63M	$443.96M	$441.59M
Shareholders' equity	$1.18B	$1.20B	$1.16B	$1.10B	$1.15B	$1.21B	$1.29B	$1.36B	$1.43B	$1.47B	$1.53B	$1.58B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$36.26M	$38.30M	$22.61M	$56.47M	$51.11M	$48.97M	$44.95M	$58.26M	$86.48M	$86.97M	$46.08M	$41.51M
Capital expenditures	$3.65M	$5.82M	$4.54M	$5.45M	$5.37M	$13.47M	$15.58M	$16.25M	$18.43M	$13.67M	$13.54M	$15.11M
Free cash flow	$32.62M	$32.47M	$18.07M	$51.02M	$45.74M	$35.50M	$29.37M	$42.01M	$68.05M	$73.30M	$32.54M	$26.40M
Investing cash flow	$24.28M	$18.38M	$34.47M	$35.72M	-$10.96M	-$502.00K	-$15.58M	-$162.86M	-$225.65M	-$30.63M	-$91.09M	$8.68M
Financing cash flow	$5.92M	-$794.00K	$8.27M	-$100.55M	$6.07M	$2.71M	$14.82M	$3.95M	$5.06M	-$1.91M	$9.03M	-$1.06M
Share buybacks	$0	—	—	—	-$1.00K	—	—	—	$0	—	—	—
Stock-based compensation	$10.79M	$13.57M	$9.56M	$10.94M	$12.10M	$13.79M	$14.23M	$15.93M	$15.26M	$14.64M	$13.66M	$14.83M
Depreciation & amortization	$7.04M	$7.52M	$7.65M	$4.15M	$4.39M	$5.01M	$5.51M	$2.49M	$4.46M	$4.57M	$5.62M	$5.47M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.